Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study.

BACKGROUND Fe2+ released from tissue iron stores may accelerate lipid peroxidation by virtue of its pro-oxidant properties and thus promote early atherogenesis. METHODS AND RESULTS The present prospective survey addresses the potential association between serum ferritin concentrations and the 5-year progression of carotid atherosclerosis as assessed by ultrasonographic follow-up evaluations. The study population comprises a random sample of 826 men and women 40 to 79 years old. Serum ferritin was one of the strongest risk predictors of overall progression of atherosclerosis. The main part of this association appeared to act through modification of the atherogenic potential of LDL cholesterol (OR [95% CI] for a 1-SD unit increase in ferritin at LDL levels of 2.5, 3.6, and 4.9 mmol/L: 1.55 [1.30 to 1.85], 1.77 [1.40 to 2.24], and 2.05 [1.50 to 2.80]; P=.0012 for effect modification). Changes in iron stores during the follow-up period modified atherosclerosis risk, in that a lowering was beneficial and further iron accumulation exerted unfavorable effects. All these findings applied equally to incident atherosclerosis and the extension of preexisting atherosclerotic lesions. The significance of prominent iron stores in the development of carotid stenosis was clearly less pronounced. Finally, ferritin and LDL cholesterol showed a synergistic association with incident cardiovascular disease and death (n=59). CONCLUSIONS The present study provided strong epidemiological evidence for a role of iron stores in early atherogenesis and suggests promotion of lipid peroxidation as the main underlying pathomechanism. This hypothesis could in part explain the sex difference in atherosclerotic vascular disease.

[1]  W. Poewe,et al.  Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) , 1996, BMJ.

[2]  R. Gillum,et al.  Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I Epidemiologic Followup Study. National Health and Nutrition Examination Survey. , 1996, American journal of epidemiology.

[3]  J. Salonen,et al.  The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression. , 1995, The American journal of cardiology.

[4]  A. Olsson,et al.  Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Araujo,et al.  Iron overload augments the development of atherosclerotic lesions in rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Gutteridge,et al.  Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material , 1995, FEBS letters.

[7]  G. Palomaki,et al.  Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subjects. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[8]  A. Folsom,et al.  No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. , 1995, American journal of epidemiology.

[9]  D. Jacobs,et al.  Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross‐over trial in male smokers , 1995, Journal of internal medicine.

[10]  L. Marzio,et al.  Cigarette smoke, ferritin, and lipid peroxidation. , 1995, American journal of respiratory and critical care medicine.

[11]  B. Halliwell,et al.  Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. , 1995, Free radical research.

[12]  M. Aviram,et al.  Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. , 1994, Atherosclerosis.

[13]  D. Williamson,et al.  Body iron stores and the risk of coronary heart disease. , 1994, The New England journal of medicine.

[14]  J. Salonen,et al.  Body iron stores and the risk of coronary heart disease. , 1994, The New England journal of medicine.

[15]  S. Kiechl,et al.  Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  G. Bellomo,et al.  LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[17]  R. Rauramaa,et al.  Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men. , 1994, European heart journal.

[18]  S. Kiechl,et al.  Alcohol Consumption and Carotid Atherosclerosis: Evidence of Dose-Dependent Atherogenic and Antiatherogenic Effects Results From the Bruneck Study , 1994, Stroke.

[19]  L. Hurley,et al.  Iron stores are not associated with acute myocardial infarction. , 1994, Circulation.

[20]  D. G. Altman,et al.  Statistical aspects of prognostic factor studies in oncology. , 1994, British Journal of Cancer.

[21]  W. Willett,et al.  Are body iron stores related to the risk of coronary heart disease? , 1994, The New England journal of medicine.

[22]  R. Gillum,et al.  Body iron stores and the risk of coronary heart disease. , 1994, The New England journal of medicine.

[23]  D. Fuchs,et al.  Increased concentrations of neopterin in carotid atherosclerosis. , 1994, Atherosclerosis.

[24]  R. Cooper,et al.  Iron status and coronary heart disease: negative findings from the NHANES I epidemiologic follow-up study. , 1994, American journal of epidemiology.

[25]  H. Morrison,et al.  Serum iron and risk of fatal acute myocardial infarction. , 1994, Epidemiology.

[26]  A. Hamsten,et al.  Stored iron levels and myocardial infarction at young age. , 1994, Atherosclerosis.

[27]  E. Rimm,et al.  Dietary iron intake and risk of coronary disease among men. , 1994, Circulation.

[28]  E. Porreca,et al.  Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[29]  M. K. Magnússon,et al.  Low iron-binding capacity as a risk factor for myocardial infarction. , 1994, Circulation.

[30]  W. Aronow Serum ferritin is not a risk factor for coronary artery disease in men and women aged > or = 62 years. , 1993, The American journal of cardiology.

[31]  S. Kiechl,et al.  Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  Qingbo Xu,et al.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.

[33]  H. P. Monteiro,et al.  Low density lipoprotein oxidation by stimulated neutrophils and ferritin. , 1992, Atherosclerosis.

[34]  O. Aruoma,et al.  Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. , 1992, The Biochemical journal.

[35]  Heikki Korpela,et al.  High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men , 1992, Circulation.

[36]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[37]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[38]  D. Reif,et al.  Ferritin as a source of iron for oxidative damage. , 1992, Free radical biology & medicine.

[39]  S. Scevola,et al.  Nutritional Status Assessment , 1994, Springer US.

[40]  J. Eaton,et al.  Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[41]  J. Manson,et al.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.

[42]  D. Blankenhorn,et al.  Arterial wall oxygenation, oxyradicals, and atherosclerosis. , 1991, Atherosclerosis.

[43]  R. Lauffer Iron stores and the international variation in mortality from coronary artery disease. , 1991, Medical hypotheses.

[44]  M. Cazzola,et al.  Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. , 1990, Blood.

[45]  Clive Osmond,et al.  Statistical Methods in Cancer Research, Vol. 2, the Design and Analysis of Cohort Studies , 1990 .

[46]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[47]  D. Harats,et al.  Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. , 1989, Atherosclerosis.

[48]  J. Sullivan The iron paradigm of ischemic heart disease. , 1989, American heart journal.

[49]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[50]  David W. Hosmer,et al.  Best subsets logistic regression , 1989 .

[51]  P. Taylor,et al.  Body iron stores and the risk of cancer. , 1988, The New England journal of medicine.

[52]  D. Steinberg,et al.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W D Flanders,et al.  Large sample confidence intervals for regression standardized risks, risk ratios, and risk differences. , 1987, Journal of chronic diseases.

[54]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[55]  A. Swaak,et al.  Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammation. , 1986, The Biochemical journal.

[56]  J. Toole,et al.  Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound. , 1986, Stroke.

[57]  S. Aust,et al.  Ferritin and superoxide-dependent lipid peroxidation. , 1985, The Journal of biological chemistry.

[58]  L. Chambless,et al.  A comparison of direct adjustment and regression adjustment of epidemiologic measures. , 1985, Journal of chronic diseases.

[59]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[60]  A. Chait,et al.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. , 1984, The Journal of clinical investigation.

[61]  E. Weinberg Iron withholding: a defense against infection and neoplasia. , 1984, Physiological reviews.

[62]  C. Finch,et al.  Perspectives in iron metabolism. , 1982, The New England journal of medicine.

[63]  J. Sullivan IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.

[64]  F. D. Weinfeld,et al.  The National Survey of Stroke. Clinical findings. , 1981, Stroke.

[65]  W. Kannel,et al.  Menopause and Risk of Cardiovascular Disease: The Framingham Study , 1976 .

[66]  Bridget Wilcken,et al.  Pathogenesis of coronary artery disease , 1969 .

[67]  J. Cook,et al.  Serum ferritin as a measure of iron stores in normal subjects. , 1974, The American journal of clinical nutrition.

[68]  J. Cook,et al.  A clinical evaluation of serum ferritin as an index of iron stores. , 1974, The New England journal of medicine.

[69]  J. Verter,et al.  Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia , 1974, Circulation.

[70]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[71]  Fritz Haber,et al.  The catalytic decomposition of hydrogen peroxide by iron salts , 1934 .